OTCMKTS:CHSYF China Medical System - CHSYF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding China Medical System Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. $1.54 0.00 (0.00%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.54▼$1.5450-Day Range$1.38▼$1.5452-Week Range$1.54▼$1.54VolumeN/AAverage Volume2,475 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsHeadlinesShort Interest About China Medical System (OTCMKTS:CHSYF) StockChina Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. Its products also comprise DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company also offers Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.Read More Receive CHSYF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for China Medical System and its competitors with MarketBeat's FREE daily newsletter. Email Address CHSYF Stock News HeadlinesMarch 27, 2023 | forbes.comChina’s Covid ‘Exit Wave’: (3) What Other Countries’ Zero-Covid Exits ShowMarch 27, 2023 | msn.comDelhi HC grants time to Centre to file reply to plea for adopting holistic approach in medical education, practiceMarch 28, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. March 24, 2023 | finanznachrichten.deCGTN: How China continues optimizing its COVID-19 response amid other outbreaksMarch 23, 2023 | msn.comChina-Russia trade surge lifts yuan use, but Russians would ‘give right arm’ for US dollarsMarch 23, 2023 | msn.comMan on probation shot at police in Old East Dallas before cop returned fire, chief saysMarch 23, 2023 | finanznachrichten.deSequana Medical NV: Sequana Medical announces additional patents for DSR® in China and the United StatesMarch 23, 2023 | marketwatch.comMedical Overtube Market Outlook and Forecast till 2028March 28, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. March 22, 2023 | bbc.comUS firms 'more negative' about doing business in ChinaMarch 22, 2023 | msn.comChina Shakes Up Bureaucracy With Eye on Technological EdgeMarch 21, 2023 | finance.yahoo.comBLA Accepted in China for Boan Biotech's Denosumab Injection (BA1102) for the Oncology IndicationsMarch 19, 2023 | msn.comWeekend Posted: What China really wants to achieve in CanadaMarch 11, 2023 | msn.comLi Qiang: China's new premier and Xi loyalistMarch 11, 2023 | msn.comXi Jinping bets on competence of Li Qiang as China new PremierMarch 9, 2023 | msn.comChinese Embassy in Zimbabwe marks 60th anniversary of Chinese Medical TeamsMarch 8, 2023 | msn.comAustralia politics live: NAB passes on full rate hike; pre-departure Covid testing to end for China, Hong Kong, Macau travellersMarch 6, 2023 | cnbc.comUkraine war live updates: Ukraine likely staging 'tactical withdrawal' in Bakhmut; Russian mercenary chief's rift with officials deepensMarch 3, 2023 | msn.comHow China's next premier went again Xi Jinping to end zero-Covid curbsFebruary 28, 2023 | msn.comRust belt province got old before it got rich, as much of China willFebruary 27, 2023 | theglobeandmail.comMorning Update: Former Trudeau advisers call for public inquiry into China’s election interferenceFebruary 24, 2023 | msn.comUkraine war – latest news: UN calls for Putin’s army to withdraw but China abstainsFebruary 23, 2023 | nytimes.comChina’s Cities Are Cutting Health Insurance, and People Are AngryFebruary 22, 2023 | msn.comUkraine Latest: Putin Lauds China Ties as Biden to Meet LeadersFebruary 21, 2023 | marketwatch.comMedical Document Management System Market Trends, Forecast and Analysis by NEW Market Insights 2023-2029February 21, 2023 | finance.yahoo.comWater Ways’ Chinese Subsidiary Finalizing Installation of a Blueberries Smart Irrigation System in ChinaFebruary 20, 2023 | theglobeandmail.comCSIS reports outline how China targets Canadian politicians, business leadersSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CHSYF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for China Medical System and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceuticals - Major Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CHSYF CUSIPN/A CIKN/A Webwww.cms.net.cn PhoneN/AFaxN/AEmployees5,292Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMr. Kong Lam (Age 58)Founder, Chairman, CEO & Pres Comp: $659.55kMs. Yanling Chen (Age 53)CFO, VP & Exec. Director Comp: $463.14kMr. Hongbing Chen (Age 56)COO, VP, Director of Sales & Marketing and Exec. Director Comp: $603.91kDr. Wai Ming Wong (Age 62)Chief Technical Officer Ms. Sanyan Wu (Age 40)Director of Legal Department & Company Sec. Key CompetitorsAcacia Pharma GroupOTCMKTS:ACPGFECO Animal Health GroupOTCMKTS:EAHGFEvolvaOTCMKTS:ELVAFFaron Pharmaceuticals OyOTC:FPHAFHansa Biopharma AB (publ)OTCMKTS:HNSBFView All Competitors CHSYF Stock - Frequently Asked Questions How have CHSYF shares performed in 2023? China Medical System's stock was trading at $1.3810 on January 1st, 2023. Since then, CHSYF stock has increased by 11.5% and is now trading at $1.54. View the best growth stocks for 2023 here. Are investors shorting China Medical System? China Medical System saw a drop in short interest in February. As of February 15th, there was short interest totaling 1,664,200 shares, a drop of 6.7% from the January 31st total of 1,784,200 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days. View China Medical System's Short Interest. What is China Medical System's stock symbol? China Medical System trades on the OTCMKTS under the ticker symbol "CHSYF." How do I buy shares of China Medical System? Shares of CHSYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is China Medical System's stock price today? One share of CHSYF stock can currently be purchased for approximately $1.54. How many employees does China Medical System have? The company employs 5,292 workers across the globe. This page (OTCMKTS:CHSYF) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.